Skip to main content

Published locations for Difficult-to-treat chronic migraine: OnabotulinumtoxinA to anti-CGRP mAbs switch shows benefit

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Difficult-to-treat chronic migraine: OnabotulinumtoxinA to anti-CGRP mAbs switch shows benefit

User login

  • Reset your password
  • /content/difficult-treat-chronic-migraine-onabotulinumtoxina-anti-cgrp-mabs-switch-shows-benefit
  • /migraine-icymi/article/261232/headache-migraine/difficult-treat-chronic-migraine-onabotulinumtoxina
  • /rheumatology/article/261232/rheumatoid-arthritis/difficult-treat-chronic-migraine-onabotulinumtoxina